TAK
Price
$15.59
Change
-$0.37 (-2.32%)
Updated
Sep 28, 6:59 PM EST
27 days until earnings call
ZTS
Price
$174.00
Change
-$0.64 (-0.37%)
Updated
Sep 28, 6:59 PM EST
34 days until earnings call

TAK vs ZTS ᐉ Comparison: Which is Better to Invest?

Header iconTAK vs ZTS Comparison
Open Charts TAK vs ZTSBanner chart's image
Takeda Pharmaceutical
Price$15.59
Change-$0.37 (-2.32%)
Volume$557.51K
CapitalizationN/A
ZOETIS
Price$174.00
Change-$0.64 (-0.37%)
Volume$318.9K
CapitalizationN/A
View a ticker or compare two or three
TAK vs ZTS Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
TAK vs. ZTS commentary
Sep 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TAK is a Hold and ZTS is a Sell.

COMPARISON
Comparison
Sep 29, 2023
Stock price -- (TAK: $15.59 vs. ZTS: $174.01)
Brand notoriety: TAK: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TAK: 83% vs. ZTS: 64%
Market capitalization -- TAK: $48.72B vs. ZTS: $81.81B
TAK [@Pharmaceuticals: Other] is valued at $48.72B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $81.81B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $81.81B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TAK’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 2 green FA rating(s).

  • TAK’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 2 green, 3 red.
According to our system of comparison, ZTS is a better buy in the long-term than TAK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TAK’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 3 bullish TA indicator(s).

  • TAK’s TA Score: 5 bullish, 5 bearish.
  • ZTS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than TAK.

Price Growth

TAK (@Pharmaceuticals: Other) experienced а -2.13% price change this week, while ZTS (@Pharmaceuticals: Other) price change was -1.48% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.79%. For the same industry, the average monthly price growth was +43.84%, and the average quarterly price growth was +11.98%.

Reported Earning Dates

TAK is expected to report earnings on Oct 26, 2023.

ZTS is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (-0.79% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for TAK with price predictions.
OPEN
A.I.dvisor published
a Summary for ZTS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ZTS($81.8B) has a higher market cap than TAK($48.7B). ZTS has higher P/E ratio than TAK: ZTS (36.76) vs TAK (24.81). ZTS YTD gains are higher at: 19.534 vs. TAK (-0.064). TAK has higher annual earnings (EBITDA): 1.15T vs. ZTS (3.54B). TAK has more cash in the bank: 369B vs. ZTS (1.71B). ZTS has less debt than TAK: ZTS (6.75B) vs TAK (4.75T). TAK has higher revenues than ZTS: TAK (4.11T) vs ZTS (8.22B).
TAKZTSTAK / ZTS
Capitalization48.7B81.8B60%
EBITDA1.15T3.54B32,580%
Gain YTD-0.06419.534-0%
P/E Ratio24.8136.7667%
Revenue4.11T8.22B50,036%
Total Cash369B1.71B21,529%
Total Debt4.75T6.75B70,378%
FUNDAMENTALS RATINGS
TAK vs ZTS: Fundamental Ratings
TAK
ZTS
OUTLOOK RATING
1..100
7373
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
10032
SMR RATING
1..100
4321
PRICE GROWTH RATING
1..100
4546
P/E GROWTH RATING
1..100
7446
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (19) in the Pharmaceuticals Major industry is somewhat better than the same rating for ZTS (69) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew somewhat faster than ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (32) in the Pharmaceuticals Generic industry is significantly better than the same rating for TAK (100) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew significantly faster than TAK’s over the last 12 months.

ZTS's SMR Rating (21) in the Pharmaceuticals Generic industry is in the same range as TAK (43) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew similarly to TAK’s over the last 12 months.

TAK's Price Growth Rating (45) in the Pharmaceuticals Major industry is in the same range as ZTS (46) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's P/E Growth Rating (46) in the Pharmaceuticals Generic industry is in the same range as TAK (74) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew similarly to TAK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TAKZTS
RSI
ODDS (%)
Bearish Trend 3 days ago
52%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
50%
MACD
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
48%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
43%
Bearish Trend 3 days ago
50%
Advances
ODDS (%)
Bullish Trend 15 days ago
47%
Bullish Trend 5 days ago
62%
Declines
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
44%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
58%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTD1118.2420.46
+1.86%
Mettler-Toledo International
QCRH48.860.33
+0.68%
QCR Holdings
SNFCA8.220.05
+0.61%
Security National Financial Corp
CCOI63.67-0.67
-1.04%
Cogent Communications Holdings
MBIO2.01-0.10
-4.74%
Mustang Bio

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with RDY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then RDY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
-2.26%
RDY - TAK
39%
Loosely correlated
+0.43%
DVAX - TAK
31%
Poorly correlated
+1.86%
EVO - TAK
31%
Poorly correlated
+1.25%
PBH - TAK
30%
Poorly correlated
-1.09%
HLN - TAK
28%
Poorly correlated
+1.99%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.38%
ELAN - ZTS
53%
Loosely correlated
+0.63%
DVAX - ZTS
43%
Loosely correlated
+1.86%
PETQ - ZTS
42%
Loosely correlated
+0.68%
EVO - ZTS
42%
Loosely correlated
+1.25%
KMDA - ZTS
41%
Loosely correlated
+3.14%
More